nach oben

Pediatric Nephrology

Erschienen in:

21.07.2018 | Educational Review

Blood-borne viral infections in pediatric hemodialysis

verfasst von: Shina Menon, Raj Munshi

Erschienen in: Pediatric Nephrology | Ausgabe 6/2019

Einloggen, um Zugang zu erhalten

Abstract

Hemodialysis patients are at increased risk for development of blood-borne viral infections. Human immunodeficiency virus (HIV), a once fatal infection, has become treatable, but continues to be associated with increased mortality. Hepatitis B and C viral infections can lead to acute and chronic hepatitis, cirrhosis, or hepatocellular carcinoma. Young children and immunocompromised patients are more likely to develop chronic disease leading to increased morbidity and mortality, as compared to the healthy population. The hemodialysis population is at increased risk of blood-borne viral infections as compared to the general population due to multiple factors. Here we review risk factors of blood-borne viral infections, strategies for prevention, and approach to therapy in the pediatric hemodialysis population.

United States Renal Data System (2015) USRDS annual data report: epidemiology of kidney disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda

Hörl WH (1999) Neutrophil function and infections in uremia. Am J Kidney Dis 33:xlv–xlviiiCrossRefPubMed

Cohen G, Horl WH (2012) Immune dysfunction in uremia: an update. Toxins (Basel) 4:962–990CrossRef

Vaziri ND, Pahl MV, Crum A, Norris K (2012) Effect of uremia on structure and function of immune system. J Ren Nutr 22:149–156CrossRefPubMedPubMedCentral

Girndt M, Sester M, Sester U, Kaul H, Kohler H (2001) Molecular aspects of T- and B-cell function in uremia. Kidney Int Suppl 78:S206–S211CrossRefPubMed

Patruta SI, Edlinger R, Sunder-Plassmann G, Hörl WH (1998) Neutrophil impairment associated with iron therapy in hemodialysis patients with functional iron deficiency. J Am Soc Nephrol 9:655–663PubMed

Martin P, Fabrizi F (2008) Hepatitis C virus and kidney disease. J Hepatol 49:613–624CrossRefPubMed

Edey M, Barraclough K, Johnson DW (2010) Review article: hepatitis B and dialysis. Nephrology (Carlton) 15:137–145CrossRef

Kidney Disease: Improving Global Outcomes (2008) KDIGO clinical practice guidelines for the prevention, diagnosis, evaluation, and treatment of hepatitis C in chronic kidney disease. Kidney Int 73(Suppl 109):S1–S99

10.

Blagg CR (2007) The early history of dialysis for chronic renal failure in the United States: a view from Seattle. Am J Kidney Dis 49:482–496CrossRefPubMed

11.

London WT, Millman I (1969) Australia antigen and viral hepatitis. Rev Fr Etud Clin Biol 14:961–963PubMed

12.

Centers for Disease Control and Prevention (1977) Hepatitis: control measures for hepatitis B in dialysis centers. Hepatitis surveillance report no. 41. Atlanta, Georgia: US Department of Health and Human Services, Public Health Service, CDC:12–17

13.

Centers for Disease Control and Prevention (2001) Recommendations for preventing transmission of infections among chronic hemodialysis patients. MMWR Morb Mortal Wkly Rep 50:1–46

14.

Burdick RA, Bragg-Gresham JL, Woods JD, Hedderwick SA, Kurokawa K, Combe C, Saito A, LaBrecque J, Port FK, Young EW (2003) Patterns of hepatitis B prevalence and seroconversion in hemodialysis units from three continents: the DOPPS. Kidney Int 63:2222–2229CrossRefPubMed

15.

Fine RN, Malekzadeh MH, Wright HT (1975) Hepatitis B in a pediatric hemodialysis unit. J Pediatr 86:349–355CrossRefPubMed

16.

Zwolińska D, Inglot M, Makulska I, Gładysz A, Szprynger K, Szczepańska M, Pietrzyk J, Zachwieja K, Zurowska A, Zachwieja J, Rajkowski T, Jobs K, Latoszyńska J, Jander A (2001) Epidemiology of HBV infections and possibilities for therapeutic actions in children and adolescents with end-stage renal failure treated with dialysis. Pol Merkur Lekarski 10:267–270PubMed

17.

Ataei N, Hosseini M, Yousefifard M, Oraii A, Ataei F, Abbasi A, Raeessi N, Moghtaderi M, Bazargani B (2018) Seroprevalence of hepatitis B and C virus infection in children with chronic kidney diseases; a historical cohort study. Int J Pediatr 6:6911–6917

18.

Shah SR, Khan MS, Alam MT, Salim A, Hussain M, Altaf A (2015) End stage renal disease: seroprevalence of hepatitises B and C along with associated aetiology and risk factors in children. J Trop Med 2015:936094CrossRefPubMedPubMedCentral

19.

Favero MS, Maynard JE, Petersen NJ, Boyer KM, Bond WW, Berquist KR, Szmuness W (1973) Letter: hepatitis-B antigen on environmental surfaces. Lancet 2:1455CrossRefPubMed

20.

Bond WW, Favero MS, Petersen NJ, Gravelle CR, Ebert JW, Maynard JE (1981) Survival of hepatitis B virus after drying and storage for one week. Lancet 1:550–551CrossRefPubMed

21.

Moloughney BW (2001) Transmission and postexposure management of bloodborne virus infections in the health care setting: where are we now? CMAJ 165:445–451PubMedPubMedCentral

22.

United States Public Health Service (2001) Updated U.S. Public Health Service guidelines for the management of occupational exposures to HBV, HCV, and HIV and recommendations for postexposure prophylaxis. MMWR Recomm Rep 50:1–52

23.

Shikata T, Karasawa T, Abe K, Uzawa T, Suzuki H, Oda T, Imai M, Mayumi M, Moritsugu Y (1977) Hepatitis B e antigen and infectivity of hepatitis B virus. J Infect Dis 136:571–576CrossRefPubMed

24.

Schillie S, Vellozzi C, Reingold A, Harris A, Haber P, Ward J, Nelson NP (2018) Prevention of hepatitis B virus infection in the United States: recommendations of the advisory committee on immunization practices. MMWR Recomm Rep 67:1–31CrossRefPubMedPubMedCentral

25.

Trinkoff AM, Le R, Geiger-Brown J, Lipscomb J (2007) Work schedule, needle use, and needlestick injuries among registered nurses. Infect Control Hosp Epidemiol 28:156–164CrossRefPubMed

26.

Schillie S, Murphy TV, Sawyer M, Ly K, Hughes E, Jiles R, de Perio MA, Reilly M, Byrd K, Ward JW, Centers for Disease Control and Prevention (2013) CDC guidance for evaluating health-care personnel for hepatitis B virus protection and for administering postexposure management. MMWR Recomm Rep 62:1–19PubMed

27.

Beltrami EM, Kozak A, Williams IT, Saekhou AM, Kalish ML, Nainan OV, Stramer SL, Fucci MC, Frederickson D, Cardo DM (2003) Transmission of HIV and hepatitis C virus from a nursing home patient to a health care worker. Am J Infect Control 31:168–115CrossRefPubMed

28.

Yasuda K, Okuda K, Endo N, Ishiwatari Y, Ikeda R, Hayashi H, Yokozeki K, Kobayashi S, Irie Y (1995) Hypoaminotransferasemia in patients undergoing long-term hemodialysis: clinical and biochemical appraisal. Gastroenterology 109:1295–1300CrossRefPubMed

29.

Karnsakul W, Schwarz KB (2017) Hepatitis B and C. Pediatr Clin N Am 64:641–658CrossRef

30.

Fontenele AM, Filho NS, Ferreira AS (2013) Occult hepatitis B in patients on hemodialysis: a review. Ann Hepatol 12:527–531CrossRefPubMed

31.

Bernieh B (2015) Viral hepatitis in hemodialysis: an update. J Transl Int Med 3:93–105CrossRefPubMedPubMedCentral

32.

Marrero JA, Lok AS (2004) Occult hepatitis B virus infection in patients with hepatocellular carcinoma: innocent bystander, cofactor, or culprit? Gastroenterology 126:347–350CrossRefPubMed

33.

Hsu HY, Chang MH, Ni YH, Chiang CL, Wu JF, Chen HL (2015) Universal infant immunization and occult hepatitis B virus infection in children and adolescents: a population-based study. Hepatology 61:1183–1191CrossRefPubMed

34.

Said ZN (2011) An overview of occult hepatitis B virus infection. World J Gastroenterol 17:1927–1938CrossRefPubMedPubMedCentral

35.

Aghakhani A, Banifazl M, Kalantar E, Eslamifar A, Ahmadi F, Razeghi E, Atabak S, Amini M, Khadem-Sadegh A, Ramezani A (2010) Occult hepatitis B virus infection in hemodialysis patients with isolated hepatitis B core antibody: a multicenter study. Ther Apher Dial 14:349–353CrossRefPubMed

36.

Sheth RD, Peskin MF, Du XL (2014) The duration of hepatitis B vaccine immunity in pediatric dialysis patients. Pediatr Nephrol 29:2029–2037CrossRefPubMed

37.

Mast EE, Margolis HS, Fiore AE, Brink EW, Goldstein ST, Wang SA, Moyer LA, Bell BP, Alter MJ, Advisory Committee on Immunization Practices (2005) A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) part 1: immunization of infants, children, and adolescents. MMWR Recomm Rep 54:1–31PubMed

38.

Drachman R, Isacsohn M, Rudensky B, Drukker A (1989) Vaccination against hepatitis B in children and adolescent patients on dialysis. Nephrol Dial Transplant 4:372–374CrossRefPubMed

39.

Petersen KM, Bulkow LR, McMahon BJ, Zanis C, Getty M, Peters H, Parkinson AJ (2004) Duration of hepatitis B immunity in low risk children receiving hepatitis B vaccinations from birth. Pediatr Infect Dis J 23:650–655CrossRefPubMed

40.

Neu AM (2012) Immunizations in children with chronic kidney disease. Pediatr Nephrol 27:1257–1263CrossRefPubMed

41.

Misurac JM, VanDeVoorde RG, Kallash M, Iorember FM, Luckritz KE, Rheault MN, Jetton JG, Turman MA, Kapur G, Twombley KE, Hashmat S, Weaver DJ, Leiser JD, Nailescu C (2017) Immunogenicity of augmented compared with standard dose hepatitis B vaccine in pediatric patients on dialysis: a Midwest Pediatric Nephrology Consortium Study. Clin J Am Soc Nephrol 12:772–778CrossRefPubMedPubMedCentral

42.

Watkins SL, Alexander SR, Brewer ED, Hesley TM, West DJ, Chan IS, Mendelman P, Bailey SM, Burns JL, Hogg RJ, Southwest Pediatric Nephrology Study Group (2002) Response to recombinant hepatitis B vaccine in children and adolescents with chronic renal failure. Am J Kidney Dis 40:365–372CrossRefPubMed

43.

Centers for Disease Control and Prevention. Guidelines for vaccinating kidney dialysis patients and patients with chronic kidney disease: summarized from recommendations of the Advisory Committee on Immunization Practices. Available at: http://www.cdc.gov/vaccines/pubs/downloads/b_dialysis_guide-508.pdf

44.

Terrault NA, Lok ASF, McMahon BJ, Chang KM, Hwang JP, Jonas MM, Brown RS Jr, Bzowej NH, Wong JB (2018) Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology 67:1560–1599CrossRefPubMed

45.

Centers for Disease Control and Prevention (2008) Infection control requirements for dialysis facilities and clarification regarding guidance on parenteral medication vials. MMWR Morb Mortal Wkly Rep 57:875–876

46.

Campbell-Yesufu OT, Gandhi RT (2011) Update on human immunodeficiency virus (HIV)-2 infection. Clin Infect Dis 52:780–787CrossRefPubMedPubMedCentral

47.

Kharsany AB, Karim QA (2016) HIV infection and AIDS in sub-Saharan Africa: current status, challenges and opportunities. Open AIDS J 10:34–48CrossRefPubMedPubMedCentral

48.

McCulloch MI, Ray PE (2008) Kidney disease in HIV-positive children. Semin Nephrol 28:585–594CrossRefPubMedPubMedCentral

49.

Centers for Disease Control and Prevention (2018) Estimated HIV incidence and prevalence in the United States, 2010–2015. HIV Surveillance Supplemental Report 2018; 23 (No. 1). http://www.cdc.gov/hiv/library/reports/hiv-surveillance.html Published March 2018. Accessed 6/8/2018

50.

Naicker S, Rahmanian S, Kopp JB (2015) HIV and chronic kidney disease. Clin Nephrol 83:32–38CrossRefPubMed

51.

Razzak Chaudhary S, Workeneh BT, Montez-Rath ME, Zolopa AR, Klotman PE, Winkelmayer WC (2015) Trends in the outcomes of end-stage renal disease secondary to human immunodeficiency virus-associated nephropathy. Nephrol Dial Transplant 30:1734–1740CrossRefPubMedPubMedCentral

52.

Eggers PW, Kimmel PL (2004) Is there an epidemic of HIV infection in the US ESRD program? J Am Soc Nephrol 15:2477–2485CrossRefPubMed

53.

Rajpoot D, Kaupke CJ, Vaziri ND, Rao TK, Pomrantz A, Fikrig S (1996) Childhood AIDS nephropathy: a 10-year experience. J Natl Med Assoc 88:493–498PubMedPubMedCentral

54.

Purswani MU, Chernoff MC, Mitchell CD, Seage GR 3rd, Zilleruelo G, Abitbol C, Andiman WA, Kaiser KA, Spiegel H, Oleske JM, IMPAACT 219/219C Study Team (2012) Chronic kidney disease associated with perinatal HIV infection in children and adolescents. Pediatr Nephrol 27:981–989CrossRefPubMedPubMedCentral

55.

Bhimma R, Purswani MU, Kala U (2013) Kidney disease in children and adolescents with perinatal HIV-1 infection. J Int AIDS Soc 16:18596CrossRefPubMedPubMedCentral

56.

Gordillo R, Kumar J, Del Rio M, Flynn JT, Woroniecki RP (2009) Outcome of dialysis in children with human immunodeficiency virus infection. Pediatr Nephrol 24:171–175CrossRefPubMed

57.

Peterman TA, Lang GR, Mikos NJ, Solomon SL, Schable CA, Feorino PM, Britz JA, Allen JR (1986) HTLV-III/LAV infection in hemodialysis patients. JAMA 255:2324–2326CrossRefPubMed

58.

Arnow PM, Fellner S, Harrington R, Leuther M (1988) False-positive results of screening for antibodies to human immunodeficiency virus in chronic hemodialysis patients. Am J Kidney Dis 11:383–386CrossRefPubMed

59.

Centers for Disease Control and Prevention (2018) Quick reference guide: recommended laboratory HIV testing algorithm for serum or plasma specimens. Available at https://stacks.cdc.gov/view/cdc/50872

60.

Branson BM, Handsfield HH, Lampe MA, Janssen RS, Taylor AW, Lyss SB, Clark JE, Centers for Disease Control and Prvention (2006) Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR Recomm Rep 55(RR-14):1–17PubMed

61.

Committee on Pediatric AIDS, Emmanuel PJ, Martinez J (2011) Adolescents and HIV infection: the pediatrician’s role in promoting routine testing. Pediatrics 128:1023–1029CrossRef

62.

World Health Organization (2013) Department of HIV/AIDS,World Health Organization: Department of Maternal Newborn Child and Adolescent Health, HIV and adolescents: guidance for HIV testing and counselling and care for adolescents living with HIV: recommendations for a public health approach and considerations for policy-makers and managers. 2013, World Health Organization,: Geneva, Switzerland. p. 1 online resource (1 PDF file (xi, 81 pages))

63.

Culp L, Caucci L (2013) State adolescent consent laws and implications for HIV pre-exposure prophylaxis. Am J Prev Med 44:S119–S124CrossRefPubMed

64.

Lehrer JA, Pantell R, Tebb K, Shafer MA (2007) Forgone health care among U.S. adolescents: associations between risk characteristics and confidentiality concern. J Adolesc Health 40:218–226CrossRefPubMed

65.

Dyer E (1993) Argentinian doctors accused of spreading AIDS. BMJ 307:584PubMed

66.

Velandia M, Fridkin SK, Cárdenas V, Boshell J, Ramirez G, Bland L, Iglesias A, Jarvis W (1995) Transmission of HIV in dialysis centre. Lancet 345:1417–1422CrossRefPubMed

67.

El Sayed NM, Gomatos PJ, Beck-Sagué CM, Dietrich U, von Briesen H, Osmanov S, Esparza J, Arthur RR, Wahdan MH, Jarvis WR (2000) Epidemic transmission of human immunodeficiency virus in renal dialysis centers in Egypt. J Infect Dis 181:91–97CrossRefPubMed

68.

Ahuja TS, O'Brien WA (2003) Special issues in the management of patients with ESRD and HIV infection. Am J Kidney Dis 41:279–291CrossRefPubMed

69.

Kuhar DT, Henderson DK, Struble KA, Heneine W, Thomas V, Cheever LW, Gomaa A, Panlilio AL, US Public Health Service Working Group (2013) Updated US public health service guidelines for the management of occupational exposures to human immunodeficiency virus and recommendations for postexposure prophylaxis. Infect Control Hosp Epidemiol 34:875–892CrossRefPubMed

70.

Boyle SM, Lee DH, Wyatt CM (2017) HIV in the dialysis population: current issues and future directions. Semin Dial 30:430–437CrossRefPubMed

71.

Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in adults and adolescents living with HIV. Department of Health and Human Services. Available at http://www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf. Accessed 6/8/18

72.

Ahuja TS, Borucki M, Grady J (2000) Highly active antiretroviral therapy improves survival of HIV-infected hemodialysis patients. Am J Kidney Dis 36:574–580CrossRefPubMed

73.

Trullàs JC, Cofan F, Barril G, Martínez-Castelao A, Jofre R, Rivera M, Martínez-Ara J, Ros S, Perez I, Moreno A, Miró JM, Spanish HIV Infection in Dialysis Study Group (2011) Outcome and prognostic factors in HIV-1-infected patients on dialysis in the cART era: a GESIDA/SEN cohort study. J Acquir Immune Defic Syndr 57:276–283CrossRefPubMed

74.

Panel on Antiretroviral Therapy and Medical Management of Children Living with HIV. Guidelines for the use of antiretroviral agents in pediatric hiv infection. Available at http://aidsinfo.nih.gov/contentfiles/lvguidelines/pediatricguidelines.pdf. Accessed 6/8/18

75.

Fissell RB, Bragg-Gresham JL, Woods JD, Jadoul M, Gillespie B, Hedderwick SA, Rayner HC, Greenwood RN, Akiba T, Young EW (2004) Patterns of hepatitis C prevalence and seroconversion in hemodialysis units from three continents: the DOPPS. Kidney Int 65:2335–2342CrossRefPubMed

76.

Youssef DM, Abdo H, Alakhras A, Adham T, Mohamoud AH (2017) Hepatitis C in children with chronic kidney disease: a single-center, Egypt. Saudi J Kidney Dis Transpl 28:102–106CrossRefPubMed

77.

Molle ZL, Baqi N, Gretch D, Hidalgo G, Tejani A, Rabinowitz SS (2002) Hepatitis C infection in children and adolescents with end-stage renal disease. Pediatr Nephrol 17:444–449CrossRefPubMed

78.

Taylor LE, Swan T, Mayer KH (2012) HIV coinfection with hepatitis C virus: evolving epidemiology and treatment paradigms. Clin Infect Dis 55(Suppl 1):S33–S42CrossRefPubMedPubMedCentral

79.

Hardy NM, Sandroni S, Danielson S, Wilson WJ (1992) Antibody to hepatitis C virus increases with time on hemodialysis. Clin Nephrol 38:44–48PubMed

80.

Chappell CA, Hillier SL, Crowe D, Meyn LA, Bogen DL, Krans EE (2018) Hepatitis C virus screening among children exposed during pregnancy. Pediatrics 141:e20173273CrossRefPubMed

81.

Greco M, Cristiano K, Leozappa G, Rapicetta M, Rizzoni G (1993) Hepatitis C infection in children and adolescents on haemodialysis and after renal transplant. Pediatr Nephrol 7:424–427CrossRefPubMed

82.

Fabrizi F, Messa P (2015) Transmission of hepatitis C virus in dialysis units: a systematic review of reports on outbreaks. Int J Artif Organs 38:471–480CrossRefPubMed

83.

Centers for Disease Control and Prevention (2016) CDC urging dialysis providers and facilities to assess and improve infection control practices to stop hepatitis C virus transmission in patients undergoing hemodialysis. Am J Transplant 16:1633–1634CrossRef

84.

Naggie S, Holland DP, Sulkowski MS, Thomas DL (2017) Hepatitis C virus postexposure prophylaxis in the healthcare worker: why direct-acting antivirals don’t change a thing. Clin Infect Dis 64:92–99CrossRefPubMed

85.

Pol S, Jadoul M, Vallet-Pichard A (2017) An update on the management of hepatitis C virus-infected patients with stage 4-5 chronic kidney disease while awaiting the revised KDIGO guidelines. Nephrol Dial Transplant 32:32–35PubMed

Titel: Blood-borne viral infections in pediatric hemodialysis
verfasst von: Shina Menon
Raj Munshi
Publikationsdatum: 21.07.2018
Verlag: Springer Berlin Heidelberg
Erschienen in: Pediatric Nephrology / Ausgabe 6/2019
Print ISSN: 0931-041X
Elektronische ISSN: 1432-198X
DOI: https://doi.org/10.1007/s00467-018-4019-y

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Blood-borne viral infections in pediatric hemodialysis

Abstract

Neu im Fachgebiet Pädiatrie

Neuer Typ-1-Diabetes bei Kindern am Wochenende eher übersehen

Neue Studienergebnisse zur Myopiekontrolle mit Atropin

Spinale Muskelatrophie: Neugeborenen-Screening lohnt sich

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

Update Pädiatrie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 6/2019

Neonatal hypertension: an educational review

Feeding modality is a barrier to adequate protein provision in children receiving continuous renal replacement therapy (CRRT)

HNF1B nephropathy has a slow-progressive phenotype in childhood—with the exception of very early onset cases: results of the German Multicenter HNF1B Childhood Registry

Asymptomatic bacteriuria in pediatric kidney transplant recipients: to treat or not to treat? A retrospective study

Augmented renal clearance: a common condition in critically ill children

Factors associated with high-cost hospitalization for peritonitis in children receiving chronic peritoneal dialysis in the United States

Neu im Fachgebiet Pädiatrie

Neuer Typ-1-Diabetes bei Kindern am Wochenende eher übersehen

Neue Studienergebnisse zur Myopiekontrolle mit Atropin

Spinale Muskelatrophie: Neugeborenen-Screening lohnt sich

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

Update Pädiatrie